drospirenone has been researched along with Pregnancy in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (7.89) | 18.2507 |
| 2000's | 14 (36.84) | 29.6817 |
| 2010's | 17 (44.74) | 24.3611 |
| 2020's | 4 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, KE; Kolodziej, EP; Lam, K; Tian, Z; Wang, R; Zhao, HN | 1 |
| Achilles, SL; Apolikhina, I; Archer, DF; Bouchard, C; Chen, MJ; Creinin, M; Foidart, JM; Jensen, JT; Jost, M; Kaunitz, AM; Piltonen, T; Suturina, L; Weyers, S; Zatik, J | 1 |
| Colli, E; Regidor, PA | 1 |
| Asadzadeh, S; Bannazadeh Baghi, H; Sadeghzadeh Oskouei, B; Shahabi, P | 1 |
| Achilles, SL; Archer, DF; Bouchard, C; Chen, MJ; Creinin, MD; Foidart, JM; Jensen, JT; Kaunitz, AM; Westhoff, CL | 1 |
| Colli, E; Palacios, S; Regidor, PA | 1 |
| Coelingh Bennink, HJ; Ebes, F; Fauser, BC; Wouters, W; Zimmerman, Y | 1 |
| Kostev, K; Rashed, AN; Ziller, M; Ziller, V | 1 |
| Bannemerschult, R; Endrikat, J; Gerlinger, C; Marr, J; Mellinger, U; Merz, M; Schellschmidt, I; Trussell, J | 1 |
| Bakas, P; Creatsas, G; Grigoriadis, C; Hassiakos, D; Liapis, A; Vlahos, NF | 1 |
| Baihua, D; Caiyan, W; Hongyu, W; Huan, S; Liangdan, T; Meiqing, X; Mulan, R; Qinping, L; Shulan, Z; Wen, D; Xiaomao, L; Xiaoyan, X; Youdi, X; Yufeng, L; Zheng'ai, X; Zhisong, M; Zirong, H; Ziyan, H | 1 |
| Ahrendt, HJ; Archer, DF; Drouin, D | 1 |
| Gao, G; Li, L; Nai, M; Wang, L | 1 |
| Cronin, M; Dinger, J; Schellschmidt, I | 1 |
| Cremer, M; Jacobs, A; Phan-Weston, S | 1 |
| Anttila, L; Bachmann, G; Hernádi, L; Klipping, C; Kunz, M; Marr, J | 1 |
| Korver, T; Mansour, D; Melis, GB; Sommer, W; Sundström-Poromaa, I; Taneepanichskul, S; Verhoeven, C; Weisberg, E | 1 |
| Lidegaard, Ø; Løkkegaard, E; Nielsen, LH; Skjeldestad, FE; Skovlund, CW | 1 |
| Anzai, Y; Heger-Mahn, D; Marr, J; Schellschmidt, I | 1 |
| Bahamondes, L; Darney, P; Kaunitz, AM; Korver, T; Sommer, W; Verhoeven, C; Westhoff, C | 1 |
| Haydardedeoglu, B; Kilicdag, EB; Parlakgumus, AH; Zeyneloglu, HB | 1 |
| Yuzpe, AA | 1 |
| Shulman, LP | 1 |
| Thorneycroft, IH | 1 |
| Oelkers, W | 1 |
| Mansour, D | 1 |
| Beier, S; Elger, W; Garfield, R; Hillisch, A; Pollow, K; Shi, SQ | 1 |
| Bachmann, G; Benda, N; Marr, J; Sampson-Landers, C; Sulak, PJ | 1 |
| Drezgić, M; Dukić, V; Ivović, M; Penezić, Z; Stojanović, M; Vujović, S; Zidverc, J | 1 |
| Cabou, C; Caillaux, D; Damase-Michel, C; Elbaz, M; Fauvel, JM; Lacroix, I; Montastruc, JL; Roncalli, J | 1 |
| Ahrendt, HJ; Bastianelli, C; Bitzer, J; Gemzell-Danielsson, K; Gómez, MA; Karskov, B; Milsom, I; Nisand, I; Oeyen, L; Page, G; Urdl, W | 1 |
| Cianci, A; De Leo, V | 1 |
| Altmann, H; Fritzemeier, KH; Fuchs, I; Klewer, M; Otto, C; Prelle, K; Vonk, R; Walter, A | 1 |
| Fritzemeier, KH; Fuhrmann, U; Krattenmacher, R; Muhn, P; Schillinger, E | 1 |
| Beier, S; Elger, W; Krattenmacher, R; Muhn, P; Schillinger, E | 1 |
| Oelkers, WK | 1 |
| Bouw, GM; Foidart, JM; Gerlinger, C; Heithecker, R; Wuttke, W | 1 |
7 review(s) available for drospirenone and Pregnancy
| Article | Year |
|---|---|
Recent innovations in oral contraception.
Topics: Acne Vulgaris; Androstenes; Contraception; Contraceptives, Oral, Hormonal; Endometrial Hyperplasia; Estradiol; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperkalemia; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Ovulation; Pregnancy; Randomized Controlled Trials as Topic; Thromboembolism; Uterine Hemorrhage | 2010 |
Oral contraception: trends over time.
Topics: Adult; Androstenes; Breast Neoplasms; Contraception; Contraceptives, Oral, Combined; Contraindications; Ethinyl Estradiol; Female; Humans; Middle Aged; Patient Compliance; Pregnancy; Progestins; Risk Factors; Thrombosis | 2002 |
Yasmin: the reason why.
Topics: Adolescent; Adult; Androstenes; Clinical Trials as Topic; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Patient Compliance; Pregnancy; Pregnancy, Unwanted; Risk Assessment; Sensitivity and Specificity | 2002 |
Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone.
Topics: Androstenes; Contraception; Contraceptives, Oral, Combined; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Mineralocorticoids; Patient Compliance; Pregnancy; Pregnancy, Unwanted; Progesterone; Progesterone Congeners; Renin-Angiotensin System; Sensitivity and Specificity | 2002 |
Experiences with Yasmin: the acceptability of a novel oral contraceptive and its effect on well-being.
Topics: Adolescent; Adult; Androstenes; Contraception; Contraceptives, Oral, Combined; Female; Humans; Middle Aged; Patient Satisfaction; Pregnancy; Premenstrual Syndrome; Quality of Life; United Kingdom; Women's Health | 2002 |
[Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Topics: Androstenes; Contraception; Contraceptives, Oral, Combined; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Evidence-Based Medicine; Female; Humans; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Patient Satisfaction; Practice Guidelines as Topic; Pregnancy; Premenstrual Syndrome; Progesterone; Quality of Life | 2007 |
Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure.
Topics: Aldosterone; Androstenes; Angiotensinogen; Animals; Blood Pressure; Contraceptives, Oral; Estrogens; Female; Humans; Mineralocorticoid Receptor Antagonists; Postmenopause; Pregnancy; Progesterone; Progestins; Rats; Renin | 1996 |
14 trial(s) available for drospirenone and Pregnancy
| Article | Year |
|---|---|
Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials.
Topics: Androstenes; Contraceptives, Oral, Combined; Estetrol; Estrogens; Ethinyl Estradiol; Female; Humans; Pregnancy; Venous Thromboembolism | 2022 |
Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results.
Topics: Androstenes; Contraceptives, Oral, Combined; Estetrol; Estrogens; Ethinyl Estradiol; Female; Humans; North America; Pregnancy | 2021 |
Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone-only pill.
Topics: Adult; Androstenes; Contraceptives, Oral; Female; Humans; Hyperkalemia; Metrorrhagia; Pregnancy; Pregnancy Rate; Prospective Studies; Pulmonary Embolism; Treatment Failure; Venous Thrombosis; Young Adult | 2019 |
The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive.
Topics: Adult; Analysis of Variance; Androstenes; Contraceptives, Oral, Combined; Cross-Over Studies; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Double-Blind Method; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Prospective Studies; Testosterone | 2013 |
Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population.
Topics: Adult; Androstenes; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Estradiol; Ethinyl Estradiol; Europe; Female; Humans; Intention to Treat Analysis; Matched-Pair Analysis; Nandrolone; Norpregnenes; Pregnancy; Pregnancy, Unwanted; Progestins; Risk Assessment; South America; Transdermal Patch; United States; Young Adult | 2014 |
Drospirenone-only oral contraceptive: results from a multicenter noncomparative trial of efficacy, safety and tolerability.
Topics: Adolescent; Adult; Androstenes; Contraception; Contraceptives, Oral, Hormonal; Europe; Female; Healthy Volunteers; Humans; Menstrual Cycle; Menstruation Disturbances; Middle Aged; Mineralocorticoid Receptor Antagonists; Pregnancy; Prospective Studies; Uterine Hemorrhage; Young Adult | 2015 |
Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20 μg/drospirenone 3mg administered in a 24/4 regimen: a pooled analysis of four open-label studies.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Humans; Medication Adherence; Pregnancy; Pregnancy Rate; Progestins; Statistics as Topic; Young Adult | 2011 |
Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol; Estrogens; Ethinyl Estradiol; Female; Humans; Megestrol; Menstrual Cycle; Metrorrhagia; Middle Aged; Mineralocorticoid Receptor Antagonists; Norpregnadienes; Pregnancy; Pregnancy Rate; Substance Withdrawal Syndrome; Young Adult | 2011 |
Suppression of ovarian activity with a low-dose 21/7-day regimen oral contraceptive containing ethinylestradiol 20 mcg/drospirenone 3 mg in Japanese and Caucasian women.
Topics: Adolescent; Adult; Androstenes; Asian People; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Mineralocorticoid Receptor Antagonists; Ovary; Ovulation; Patient Compliance; Pregnancy; White People; Young Adult | 2012 |
Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17β-estradiol: a randomized controlled trial.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Female; Humans; Kaplan-Meier Estimate; Megestrol; Middle Aged; Norpregnadienes; Pregnancy; Proportional Hazards Models; Young Adult | 2012 |
IVF/ICSI outcomes of the OCP plus GnRH agonist protocol versus the OCP plus GnRH antagonist fixed protocol in women with PCOS: a randomized trial.
Topics: Adult; Androstenes; Clinical Protocols; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Sperm Injections, Intracytoplasmic; Young Adult | 2012 |
Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Headache; Humans; Patient Compliance; Patient Satisfaction; Pregnancy; Progesterone Congeners; Uterine Hemorrhage | 2004 |
Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
Topics: Adolescent; Adult; Androstenes; Contraception; Contraceptive Agents; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Patient Compliance; Patient Satisfaction; Pregnancy; Progesterone Congeners; Treatment Outcome | 2006 |
A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel.
Topics: Adult; Androstenes; Body Weight; Contraceptives, Oral, Synthetic; Desogestrel; Europe; Female; Humans; Menstrual Cycle; Menstruation Disturbances; Pregnancy; Pregnancy Rate; Premenstrual Syndrome; Progesterone Congeners | 2000 |
17 other study(ies) available for drospirenone and Pregnancy
| Article | Year |
|---|---|
Biotransformation of Current-Use Progestin Dienogest and Drospirenone in Laboratory-Scale Activated Sludge Systems Forms High-Yield Products with Altered Endocrine Activity.
Topics: Androstenes; Biotransformation; Female; Humans; Laboratories; Nandrolone; Pregnancy; Progestins; Sewage | 2021 |
The progestin-only pills drospirenone 4 mg and desogestrel 0.075 mg as an option for the management of dysmenorrhea and mastodynia.
Topics: Contraceptives, Oral, Combined; Desogestrel; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Mastodynia; Pregnancy; Progesterone Congeners; Progestins | 2022 |
Pregnancy after mumps: a case report.
Topics: Adult; Androstenes; Female; Humans; Iran; Mineralocorticoid Receptor Antagonists; Mumps; Oophoritis; Pregnancy; Pregnancy Outcome; Progesterone; Reproductive Techniques, Assisted; Urogenital Abnormalities; Uterus | 2019 |
The prescribing of contraceptives for adolescents in German gynecologic practices in 2007 and 2011: a retrospective database analysis.
Topics: Adolescent; Androstenes; Child; Chlormadinone Acetate; Contraceptive Agents; Desogestrel; Drug Prescriptions; Drug Utilization; Female; Germany; Gynecology; Humans; Levonorgestrel; Menstruation Disturbances; Practice Patterns, Physicians'; Pregnancy; Pregnancy in Adolescence; Retrospective Studies | 2013 |
Effect of a low dose combined oral contraceptive pill on the hormonal profile and cycle outcome following COS with a GnRH antagonist protocol in women over 35 years old.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Menstrual Cycle; Ovulation Induction; Pregnancy; Pregnancy Rate; Treatment Outcome | 2014 |
[Efficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 µg in a 24+4-day regimen in China].
Topics: Adolescent; Adult; Androstenes; Body Weight; China; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Menstruation; Mineralocorticoid Receptor Antagonists; Pregnancy; Pregnancy Rate; Treatment Outcome; Uterine Hemorrhage; Young Adult | 2014 |
[Comparison among measures to prevent intrauterine adhesions after artificial abortion].
Topics: Abortion, Induced; Androstenes; Endometrium; Ethinyl Estradiol; Female; Humans; Hyaluronic Acid; Menstrual Cycle; Menstruation; Pregnancy; Tissue Adhesions | 2016 |
Rate of pregnancy after using drospirenone and other progestin-containing oral contraceptives.
Topics: Adult; Androstenes; Cohort Studies; Contraceptives, Oral, Hormonal; Europe; Female; Fertility; Humans; Mineralocorticoid Receptor Antagonists; Population Surveillance; Pregnancy; Pregnancy Rate; Progestins; Time Factors; Young Adult | 2009 |
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.
Topics: Adolescent; Adult; Androstenes; Anticoagulants; Cohort Studies; Confounding Factors, Epidemiologic; Contraceptives, Oral; Denmark; Desogestrel; Dose-Response Relationship, Drug; Epidemiologic Methods; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Mineralocorticoid Receptor Antagonists; Norpregnenes; Pregnancy; Time Factors; Venous Thromboembolism; Young Adult | 2011 |
ACOG Committee Opinion Number 540: Risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills.
Topics: Androstenes; Contraceptives, Oral; Female; Humans; Mineralocorticoid Receptor Antagonists; Pregnancy; Risk Factors; Venous Thromboembolism | 2012 |
Safety and efficacy of a new oral contraceptive containing drospirenone.
Topics: Androstenes; Body Weight; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Pregnancy; Progesterone Congeners; Randomized Controlled Trials as Topic | 2002 |
Conception and pharmacodynamic profile of drospirenone.
Topics: Androgen Antagonists; Androstenes; Animals; Blood Pressure; Central Nervous System; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Fertilization; Humans; Kidney; Male; Mineralocorticoid Receptor Antagonists; Models, Chemical; Models, Molecular; NG-Nitroarginine Methyl Ester; Pregnancy; Protein Binding; Rats; Rats, Wistar; Renin-Angiotensin System; Sex Factors; Time Factors | 2003 |
Drospirenone in the treatment of severe premenstrual cerebral edema in a woman with antiphospholipid syndrome, lateral sinus thrombosis, situs inversus and epileptic seizures.
Topics: Abortion, Habitual; Adult; Androstenes; Anticoagulants; Antiphospholipid Syndrome; Brain Edema; Diuretics; Epilepsy; Female; Humans; Intracranial Pressure; Lateral Sinus Thrombosis; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Mutation; Pregnancy; Premenstrual Syndrome; Progesterone; Prolactin; Prothrombin; Situs Inversus | 2005 |
[Myocardial infarction in a young female smoker taking oral contraception].
Topics: Adult; Androstenes; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Myocardial Infarction; Pregnancy; Pregnancy, Ectopic; Smoking | 2006 |
Comparative analysis of the uterine and mammary gland effects of drospirenone and medroxyprogesterone acetate.
Topics: Androstenes; Animals; Cell Proliferation; Epithelium; Female; Gene Expression; Male; Mammary Glands, Animal; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Ovariectomy; Pregnancy; Pregnancy Maintenance; Progesterone Congeners; Uterus | 2008 |
Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity.
Topics: Androgen Antagonists; Androstenes; Animals; Endometrium; Estradiol Congeners; Female; Humans; Macaca fascicularis; Male; Mineralocorticoids; Orchiectomy; Ovulation; Pregnancy; Pregnancy Maintenance; Progesterone Congeners; Rabbits; Rats; Receptors, Cell Surface; Sex Differentiation; Transcriptional Activation | 1995 |
Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models.
Topics: Androgen Antagonists; Androstenes; Animals; Endometrium; Ethinyl Estradiol; Female; Male; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Orchiectomy; Ovariectomy; Ovulation; Pregnancy; Pregnancy Maintenance; Progesterone; Rabbits; Rats; Sex Differentiation | 1995 |